The performance of the clinical pharmacist in pharmaceutical care and intervention in cases of polymedicated elderly people: an integrative review
DOI:
https://doi.org/10.33448/rsd-v12i1.39332Keywords:
Clinical Pharmacist; Pharmaceutical care; Elderly; Multimorbidity; Polypharmacy.Abstract
The life expectancy of the population has increased and improved over the years due to the quality of living conditions, housing and health. However, it is understandable that the elderly are susceptible to multiple diseases due to a variety of factors. It is known that due to the high prevalence of non-communicable chronic diseases, the use of drugs has increased significantly, accompanied by higher incidences of polypharmacy. Therefore, pharmaceutical care in elderly and polydrug populations is extremely important for monitoring, not only to promote the rational use of drugs, but also to provide better adherence to treatment and, consequently, better clinical and economic results. In this way, the present research is an integrative review to analyze evidence in the literature regarding the role of the clinical pharmacist in pharmaceutical care, as well as their interventions and the impacts caused on polymedicated elderly. For this, data collection was carried out from secondary sources, through a bibliographic survey in national and international databases. 834 articles were found, and only 20 studies were used for the present research. The results obtained in this study can demonstrate that the performance of pharmaceutical care and its intervention in geriatric and polymedicated patients can adjust doses, reduce drug interactions and reduce costs, in addition to improving the quality of life of these patients.
References
Alcântara, A. O. (2016). Da Política Nacional do Idoso ao Estatuto do Idoso: a difícil construção de um sistema de garantias de direitos da pessoa idosa. In: Alcântara, A. O., Camarano, A. A., & Giacomin, K. C. Política nacional do idoso: velhas e novas questões. Rio de Janeiro: Ipea., 359-377.
Alhusein, N., Macaden, L., Smith, A., Stoddart, K. M., Taylor, A. J., Killick, K., ... & Watson, M. C. (2018). ‘Has she seen me?’: a multiple methods study of the pharmaceutical care needs of older people with sensory impairment in Scotland. BMJ open, 8(8), 1-8.
Arriagada, L., Carrasco, T., & Araya, M. (2020). Polifarmacia y deprescripción en personas mayores. Revista Médica Clínica Las Condes, 31(2), 204-210.
Bardin, L. (1977). L'analyse de contenu. Paris: Presses universitaires de France. 70, 1-223.
Bezerra, P. A., Nunes, J. W., & Moura, L. B. D. A. (2021). Envelhecimento e isolamento social: uma revisão integrativa. Acta Paulista de Enfermagem, 34, 1-9.
Caldas, A. L. L., Sá, S. P. C., & Oliveira Filho, V. D. C. (2020). Perceptions of pharmaceutical services among elderly people on polymedication. Revista Brasileira de Enfermagem, 73, 1-8.
Chen, P. Z., Wu, C. C., & Huang, C. F. (2020). Clinical and economic impact of clinical pharmacist intervention in a hematology unit. Journal of Oncology Pharmacy Practice, 26(4), 866-872.
Clerencia-Sierra, M., Calderón-Larrañaga, A., Martínez-Velilla, N., Vergara-Mitxeltorena, I., Aldaz-Herce, P., Poblador-Plou, B., ... & Prados-Torres, A. (2015). Multimorbidity patterns in hospitalized older patients: associations among chronic diseases and geriatric syndromes. PLoS One, 10(7), e0132909, 1-14.
Corrêa, C. R. S., Ramos, L. S., da Silva, T. M., Leal, L. A., de Melo, D. B., Tonon, L. R., & de Lima Merola, Y. (2021). A Polifarmácia no Público Idoso: Perigos, Tendências e Conflitos de Interesse/Polypharmacy in the Elderly Public: Dangers, Trends and Conflicts of Interest. Saúde em Foco, 8(1), 63-75.
Cosco, T. D., Howse, K., & Brayne, C. (2017). Healthy ageing, resilience and wellbeing. Epidemiology and Psychiatric Sciences, 26(6), 579-583.
Crealey, G. E., Sturgess, I. K., McElnay, J. C., & Hughes, C. M. (2003). Pharmaceutical care programmes for the elderly. Pharmacoeconomics, 21(7), 455-465.
Dagnew, S. B., Binega Mekonnen, G., Gebeye Zeleke, E., Agegnew Wondm, S., & Yimer Tadesse, T. (2022). Clinical Pharmacist Intervention on Drug-Related Problems among Elderly Patients Admitted to Medical Wards of Northwest Ethiopia Comprehensive Specialized Hospitals: A Multicenter Prospective, Observational Study. BioMed Research International, 1-11.
de Grégori, J., Pistre, P., Boutet, M., Porcher, L., Devaux, M., Pernot, C., ... & Boulin, M. (2020). Clinical and economic impact of pharmacist interventions in an ambulatory hematology–oncology department. Journal of Oncology Pharmacy Practice, 26(5), 1172-1179.
de Sá Godoi, D. R., Nascimento, K. B. R., Nunes, K. J. F., Silva, T. T. A., & Da Silva, T. K. D. A. (2021). Polifarmácia e ocorrência de interações medicamentosas em idosos. Brazilian Journal of Development, 7(3), 30946-30959.
dos Santos, G. R., Araújo, H. S., Leal, V. S., & Rambo, D. F. (2021). Atenção farmacêutica ao idoso na polifarmácia. Revista Ibero-Americana de Humanidades, Ciências e Educação, 7(5), 709-723.
Dziechciaz, M., & Filip, R. (2014). Biological psychological and social determinants of old age: Bio-psycho-social aspects of human aging. Annals of Agricultural and Environmental Medicine, 21(4),835-838.
Ertuna, E., Arun, M. Z., Ay, S., Koçak, F. Ö. K., Gökdemir, B., & İspirli, G. (2019). Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study. Clinical Interventions in Aging, 14, 587-600.
Hailu, B. Y., Berhe, D. F., Gudina, E. K., Gidey, K., & Getachew, M. (2020). Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions. BMC geriatrics, 20(1), 1-8.
Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007). Polypharmacy in elderly patients. The American journal of geriatric pharmacotherapy, 5(4), 345-351.
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008). Interventions for enhancing adherence to prescribed medications. Cochrane Database Syst Rev, (2), 1-132.
Hazen, A. C., Zwart, D. L., Poldervaart, J. M., de Gier, J. J., de Wit, N. J., de Bont, A. A., & Bouvy, M. L. (2019). Non-dispensing pharmacists’ actions and solutions of drug therapy problems among elderly polypharmacy patients in primary care. Family practice, 36(5), 544-551.
Henrique-Sanches, B. C., de Lourdes Caldana, M., & Lauris, J. R. P. (2021). Estudo dos hábitos de vida, doenças crônicas não transmissíveis, polifarmácia e interações medicamentosas em pacientes pós acidente vascular cerebral. Brazilian Journal of Development, 7(12), 111333-111348.
Ho, I. C., Chenoweth, L., & Williams, A. (2021, March). Older People’s Experiences of Living with, Responding to and Managing Sensory Loss. In Healthcare Vol. 9, No. 3, 329, 1-16.
IBGE, (2018). Instituto Brasileiro de Geografia e Estatística: Projeção da População do Brasil por sexo e idade. https://ftp.ibge.gov.br/Projecao_da_Populacao/Projecao_da_Populacao_2018/projecoes_2018_populacao_2010_2060_20200406.xls
Ivama, A. M., Noblat, L., Castro, M. S. D., Jaramillo, N. M., & Rech, N. (2002). Consenso brasileiro de atenção farmacêutica: proposta. In Consenso brasileiro de atenção farmacêutica: proposta, 24-24.
Khan, H. T. (2019). Population ageing in a globalized world: Risks and dilemmas?. Journal of evaluation in clinical practice, 25(5), 754-760.
Kim, A. J., Lee, H., Shin, E. J., Cho, E. J., Cho, Y. S., Lee, H., & Lee, J. Y. (2021). Pharmacist-led collaborative medication management for the elderly with chronic kidney disease and polypharmacy. International journal of environmental research and public health, 18(8), 4370, 1-8.
Koster, E. S., Philbert, D., & Bouvy, M. L. (2021). Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies. Research in Social and Administrative Pharmacy, 17(1), 2002-2004.
Lee, S. W. H., Mak, V. S. L., & Tang, Y. W. (2019). Pharmacist services in nursing homes: a systematic review and meta‐analysis. British journal of clinical pharmacology, 85(12), 2668-2688.
Lin, H. W., Lin, C. H., Chang, C. K., Chou, C. Y., Yu, I. W., Lin, C. C., ... & Hsieh, Y. W. (2018). Economic outcomes of pharmacist-physician medication therapy management for polypharmacy elderly: a prospective, randomized, controlled trial. Journal of the Formosan Medical Association, 117(3), 235-243.
Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014). Clinical consequences of polypharmacy in elderly. Expert opinion on drug safety, 13(1), 57-65.
Marín-Gorricho, R., Lozano, C., Ramalle-Gómara, E., Hurtado-Gómez, M. F., Pérez-Zuazo, R., & Molpeceres-García Del Pozo, J. (2022, January). Impact of pharmaceutical care in polymedicated patients admitted to a geriatric ward. In Anales del Sistema Sanitario de Navarra, 1-11.
Martínez-Sotelo, J., Pinteño-Blanco, M., García-Ramos, R., & Cadavid-Torres, M. I. (2021). Adecuación de la prescripción en pacientes mayores polimedicados en atención primaria. Ensayo clínico controlado aleatorizado por grupos PHARM-PC. Atención Primaria, 53(10), 102124, 1-10.
Mikeal R. L., Brown T. R., Lazarus H. L., Vinson M. C. (1975). Quality of pharmaceutical care in hospitals. Am J Hosp Pharm, 32, 567–574.
Ministério da Justiça. (2022). Estatuto da Pessoa idosa: lei federal nº 14.423, de 22 de julho de 2022. Brasília, DF: Planalto, 2022. https://www.planalto.gov.br/ccivil_03/_Ato2019-2022/2022/Lei/L14423.htm
Ministério da Saúde. (2006). Política Nacional de Saúde da Pessoa Idosa: Portaria nº 2.528 de 19 de outubro de 2006. Brasília, DF, 2006. https://bvsms.saude.gov.br/bvs/saudelegis/gm/2006/prt2528_19_10_2006.html
Miranda, G. M. D., Mendes, A. D. C. G., & Silva, A. L. A. D. (2016). O envelhecimento populacional brasileiro: desafios e consequências sociais atuais e futuras. Revista brasileira de geriatria e gerontologia, 19, 507-519.
Moher D., Liberati A., Tetzlaff J., Altman D. G., The Prisma Group. (2015). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The Prisma Statement. Epidemiol. Serv. Saúde., 24(2):335-342.
Mortazavi, S. S., Shati, M., Keshtkar, A., Malakouti, S. K., Bazargan, M., & Assari, S. (2016). Defining polypharmacy in the elderly: a systematic review protocol. BMJ open, 6(3), e010989, 1-4.
Mouazer, A., Tsopra, R., Sedki, K., Letord, C., & Lamy, J. B. (2022). Decision-support systems for managing polypharmacy in the elderly: A scoping review. Journal of Biomedical Informatics, 104074, 1-12.
Navickas, R., Petric, V. K., Feigl, A. B., & Seychell, M. (2016). Multimorbidity: what do we know? What should we do?. Journal of comorbidity, 6(1), 4-11.
Oliveira, A. S. (2019). Transição demográfica, transição epidemiológica e envelhecimento populacional no Brasil. Hygeia-Revista Brasileira de Geografia Médica e da Saúde, 15(32), 69-79.
Oliveira, J. M. B. D., Vera, I., Lucchese, R., Silva, G. C., Tomé, E. M., & Elias, R. A. (2018). Envelhecimento, saúde mental e suicídio. Revisão integrativa. Revista Brasileira de Geriatria e Gerontologia, 21, 488-498.
Ooi, K. (2019). Evaluation of a pharmacist-led intervention on polypharmacy. Nihon Ronen Igakkai zasshi. Japanese Journal of Geriatrics, 56(4), 498-503.
Pereira, K. G., Peres, M. A., Iop, D., Boing, A. C., Boing, A. F., Aziz, M., & d’Orsi, E. (2017). Polifarmácia em idosos: um estudo de base populacional. Revista Brasileira de Epidemiologia, 20, 335-344.
Porciúncula, R. D. C. R. D., Carvalho, E. F. D., Barreto, K. M. L., & Leite, V. M. M. (2014). Perfil socioepidemiológico e autonomia de longevos em Recife-PE, Nordeste do Brasil. Revista brasileira de Geriatria e Gerontologia, 17, 315-325.
Reis, W. C. T., Scopel, C. T., Correr, C. J., & Andrzejevski, V. M. S. (2013). Análise das intervenções de farmacêuticos clínicos em um hospital de ensino terciário do Brasil. Einstein (São Paulo), 11, 190-196.
Renaudin, P., Coste, A., Audurier, Y., Berbis, J., Canovas, F., Jalabert, A., ... & Breuker, C. (2021). Clinical, economic, and organizational impact of the clinical pharmacist in an orthopedic and trauma surgery department. Journal of Patient Safety, 17(8), 1507-1513.
Salive, M. E. (2013). Multimorbidity in older adults. Epidemiologic reviews, 35(1), 75-83.
Samir Abdin, M., Grenier-Gosselin, L., & Guénette, L. (2020). Impact of pharmacists' interventions on the pharmacotherapy of patients with complex needs monitored in multidisciplinary primary care teams. International Journal of Pharmacy Practice, 28(1), 75-83.
Santos, C. M. D. C., Pimenta, C. A. D. M., & Nobre, M. R. C. (2007). The PICO strategy for the research question construction and evidence search. Revista latino-americana de enfermagem, 15, 508-511.
Saseen, J. J., Ripley, T. L., Bondi, D., Burke, J. M., Cohen, L. J., McBane, S., ... & Vande Griend, J. P. (2017). ACCP clinical pharmacist competencies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 37(5), 630-636.
Sevilla-Sánchez D., Tuset-Creus M. (2020). Pharmaceutical care in hospitalized patients (management of the covid-19 pandemic crisis. a new challenge for pharmacy services). Farm Hosp. 2020 jun 12;44(7):28-31.
Silva, B. B., & Fegadolli, C. (2020). Implementation of pharmaceutical care for older adults in the brazilian public health system: a case study and realistic evaluation. BMC health services research, 20(1), 1-14.
Silva, M. F., Assumpção, D. D., Francisco, P. M. S. B., Neri, A. L., Yassuda, M. S., & Borim, F. S. A. (2021). Morbidades e associações com autoavaliação de saúde e capacidade funcional em idosos. Revista Brasileira de Geriatria e Gerontologia, 23, 1-12.
Sinha, A., Mukherjee, S., Tripathi, S., & Dutta, S. (2021). Issues and challenges of polypharmacy in the elderly: A review of contemporary Indian literature. Journal of Family Medicine and Primary Care, 10(10), 3544-3547.
Snell, R., Langran, T., & Donyai, P. (2017). Patient views about polypharmacy medication review clinics run by clinical pharmacists in GP practices. International journal of clinical pharmacy, 39(6), 1162-1165.
Souza, E. M. D., Silva, D. P. P., & Barros, A. S. D. (2021). Educação popular, promoção da saúde e envelhecimento ativo: uma revisão bibliográfica integrativa. Ciência & Saúde Coletiva, 26, 1355-1368.
Souza, M. T. D., Silva, M. D. D., & Carvalho, R. D. (2010). Revisão integrativa: o que é e como fazer. Einstein (São Paulo), 8, 102-106.
Stafford, G., Villén, N., Roso-Llorach, A., Troncoso-Mariño, A., Monteagudo, M., & Violán, C. (2021). Combined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care. International journal of environmental research and public health, 18(17), 9216, 1-22.
Strand, L. M., Guerrero, R. M., Nickman, N. A., & Morley, P. C. (1990). Integrated patient-specific model of pharmacy practice. American Journal of Hospital Pharmacy, 47(3), 550-554.
Stuhec, M., & Zorjan, K. (2022). Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy. Scientific Reports, 12(1), 1-8.
Stuhec, M., Gorenc, K., & Zelko, E. (2019). Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation. BMC Health Services Research, 19(1), 1-9.
Szilvay, A., Somogyi, O., Dobszay, A., Meskó, A., Zelkó, R., & Hankó, B. (2021). Analysis of interaction risks of patients with polypharmacy and the pharmacist interventions performed to solve them—A multicenter descriptive study according to medication reviews in Hungarian community pharmacies. PloS one, 16(6), e0253645, 1-18.
Tavares, D. M. D. S., & Dias, F. A. (2012). Capacidade funcional, morbidades e qualidade de vida de idosos. Texto & Contexto-Enfermagem, 21, 112-120.
Veras, R. (2009). Envelhecimento populacional contemporâneo: demandas, desafios e inovações. Revista de saúde pública, 43, 548-554.
Wang, T. C., Trezise, D., Ku, P. J., Lu, H. L., Hsu, K. C., & Hsu, P. C. (2019). Effect of Pharmacist Intervention on a Population in Taiwan with High Healthcare Utilization and Excessive Polypharmacy. International Journal of Environmental Research and Public Health, 16(12), 2208, 1-9.
Wastesson, J. W., Morin, L., Tan, E. C., & Johnell, K. (2018). An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert opinion on drug safety, 17(12), 1185-1196.
Werder, S. F., & Preskorn, S. H. (2003). Managing polypharmacy: Walking the fine line between help and harm. Current Psychiatry Online, 2(2), 24-36.
Whitman, A., DeGregory, K., Morris, A., Mohile, S., & Ramsdale, E. (2018). Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study. Supportive Care in Cancer, 26(12), 4105-4113.
Whittemore, R., & Knafl, K. (2005). The integrative review: updated methodology. Journal of advanced nursing, 52(5), 546-553.
World Health Organization. (2016). Noncommunicable diseases. https://www.who.int/data/gho/data/themes/noncommunicable-diseases#:~:text=Noncommunicable%20diseases%20(NCDs)%2C%20such,economic%20development%20of%20many%20countries.
World Health Organization. (2021). Noncommunicable diseases. https://www.who.int/health-topics/noncommunicable-diseases#tab=tab_3
Yasu, T., Koinuma, M., Hayashi, D., Horii, T., Yashiro, Y., Furuya, J., ... & Abe, K. (2018). Association between polypharmacy and clinical ward pharmacy services in hospitals in Tokyo. Geriatrics & gerontology international, 18(1), 187-188.
Zole E. & Ranka R. Mitochondria, its DNA and telomeres in ageing and human population. Biogerontology, 19(3-4):189-208.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Rakhel Dayanne Damasceno Silva; Breno Vinicius Espindola Cunha; Rose Cristina Damasceno Silva; Sabrina de Carvalho Cartágenes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
